Skip to main content
Premium Trial:

Request an Annual Quote

Ambry Genetics Taps Isilon Storage System to Hold Genomic Data


EMC's Isilon said this week that Ambry Genetics has selected its scale-out network attached storage platform to support gene sequencing activities at its CLIA-certified clinical laboratory in Aliso Viejo, Calif.

Isilon said that Ambry Genetics purchased its X-Series platform as well as SnapShotIQ, SmartConnect, and SmartQuotas software applications.

Ambry plans to use the new system to hold its sequencing data and to support bioinformatics capabilities for its clinical diagnostics and genomic services businesses.

Chris Medley, Ambry's director of information technology, said that the new system improves on an existing blade-based rack server, which couldn’t keep pace with the company's growing storage needs.

"We were adding more and more blades and filling up the rack fast, and it was clear what we had wasn't offering the scalability or performance we needed," he explained in a statement.

"We soon found we could leverage an Isilon system to handle our storage needs at a fraction of the cost, and that it will allow us to achieve some things, like data tiering, we couldn't have achieved before," Medley said.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.